Interim Report to 30 September 2015 is now available to view via the following link. The PDF report will download automatically when clicked.
Access to AFT FY16 Interim Report
Similar articles
AFT introduces new HYLO-FRESH and HYLO-FORTE
AFT Pharmaceuticals is pleased to announce the launch of new HYLO®-FRESH and HYLO- FORTE® eye drops to the Australian market.
Read more
AFT Pharmaceuticals announces capital raising to support liquidity and optimise capital structure
AFT Pharmaceuticals (NZX:AFT, ASX:AFP) (AFT, the Company), Atkinson Family Trust (AF Trust) and CRG today announce a capital raising to increase liquidity and reduce debt.
Read more
AFT welcomes new codeine medicine restrictions
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today welcomes Medsafe’s decision to classify all medicines containing codeine as prescription medicines.
Read more